Overview

Evaluation of the Antinociceptive and Analgesic Effects of Milnacipran

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
Evaluation of the antinociceptive effect of 7 weeks of treatment with milnacipran, compared to placebo, in fibromyalgia out-patients
Phase:
Phase 2
Details
Lead Sponsor:
Pierre Fabre Medicament
Treatments:
Analgesics
Levomilnacipran
Milnacipran